Zimmer Biomet (ZBH) financial statements

+111.2%since 2007
FY2025 revenue
$8.2B▲ +7.2%
FY2025 net income
$705M▼ −22.0%
FY2025 diluted EPS
$3.55▼ −19.9%
FY2025 free cash flow
$1.5B▲ +13.7%

Zimmer Biomet income statement

Zimmer Biomet income statement
USD millionsFY2025FY2024FY2023
Period ended31 Dec 202531 Dec 202431 Dec 2023
Revenue8,2327,6797,394
Operating income1,0981,2861,278
Pretax income8311,0371,067
Net income7059041,024
Diluted earnings per share3.554.434.88

Zimmer Biomet balance sheet

Zimmer Biomet balance sheet
USD millionsFY2025FY2024FY2023
Period ended31 Dec 202531 Dec 202431 Dec 2023
Cash and cash equivalents592526416
Total assets23,09221,36521,497
Total liabilities10,3868,8899,009
Total equity12,70612,47612,488
Long-term debt6,9325,3424,868

Zimmer Biomet cash flow statement

Zimmer Biomet cash flow statement
USD millionsFY2025FY2024FY2023
Period ended31 Dec 202531 Dec 202431 Dec 2023
Operating cash flow1,6971,4991,582
Capital expenditure-224-204-291
Free cash flow (derived)1,4731,2961,291
Dividends paid-190-196-201
Share repurchases-487-868-692

Quarterly highlights

Quarterly highlights
USD millionsQ3 FY2026Q2 FY2026Q1 FY2026Q4 FY2025
Period ended30 Sep 202630 Jun 202631 Mar 202631 Dec 2025
Revenue (derived)2,0632,1772,0872,244
Operating income (derived)308326373155
Net income (derived)192198238139
Diluted earnings per share1.001.031.22n/a
Operating cash flow (derived)560448359517
Total assets23,53922,79822,72223,092

Zimmer Biomet major shareholders

Zimmer Biomet major shareholders
HolderShare of classSharesFiled
Dodge & Cox12.5%24,124,73514 August 2026
BlackRock, Inc.7.8%15,573,18717 April 2025
Vanguard Capital Management7.5%14,767,52730 April 2026
Capital International Investors6.4%12,438,36612 August 2026
HARRIS ASSOCIATES L P6.2%12,264,70318 February 2026

Zimmer Biomet 10-K and SEC filings

Zimmer Biomet 10-K and SEC filings
FiledFormTypeDescription
12 November 20268-KCurrent reportCurrent report
4 November 202610-QQuarterly reportQuarterly report
4 November 20268-KCurrent reportCurrent report
8 September 20268-KCurrent reportCurrent report
5 August 20268-KCurrent reportCurrent report
5 August 202610-QQuarterly reportQuarterly report
5 August 20268-KCurrent reportCurrent report
29 June 20268-KCurrent reportCurrent report

Common questions

What was Zimmer Biomet's revenue in fiscal 2025?

Zimmer Biomet reported $8.2 billion in revenue for fiscal 2025, the year ended 31 December 2025, up 7.2% from fiscal 2024.

What was Zimmer Biomet's net income in fiscal 2025?

Zimmer Biomet reported net income of $705 million for fiscal 2025, the year ended 31 December 2025, down 22.0% from fiscal 2024. Diluted earnings per share were $3.55.

What was Zimmer Biomet's free cash flow in fiscal 2025?

Zimmer Biomet had $1.5 billion in free cash flow in fiscal 2025. Operating cash flow was $1.7 billion and capital expenditure was $225 million.

What were Zimmer Biomet's total assets at the end of fiscal 2025?

Zimmer Biomet reported total assets of $23.1 billion at the end of fiscal 2025, the year ended 31 December 2025.

How much Zimmer Biomet history do I get?

Every account gets the full history, annual and quarterly, with first reported values and as of dates.